Renate Sekul

发表

Discovery of Thrombin Inhibitor Fragments from Chemical Microarray Screening

Dirk Tomandl, Oliver Keil, K. Burkert, 2006 .

SPR-based fragment screening: advantages and applications.

T Neumann, H-D Junker, K Schmidt, 2007, Current topics in medicinal chemistry.

Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1.

R. Kraft, B. Lüscher, R. Talanian, 2001, The Biochemical journal.

SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients

M. Müller, V. Corman, C. Drosten, 2021, Frontiers in Immunology.

Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.

Zhaoming Xiong, B. Farmer, Qiang Zhang, 2009, Bioorganic & medicinal chemistry letters.

Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions

D. Agard, E. Masliah, G. Tóth, 2019, Scientific Reports.

Antibody purification by affinity chromatography based on small molecule affinity ligands identified by SPR-based screening of chemical microarrays.

R. Freitag, B. Kalbfuss-Zimmermann, F. Hilbrig, 2011, Journal of chromatography. A.

SPR Screening of Chemical Microarrays for Fragment‐Based Discovery

T. Neumann, R. Sekul, Renate Sekul, 2011 .

Design and Discovery of Novel, Potent Pyrazinone-Based Thrombin Inhibitors with a Solubilizing P1-P2-Linker

V. Matassa, J. Schamberger, C. Rosenbaum, 2006 .

Custom chemical microarray production and affinity fingerprinting for the S1 pocket of factor VIIa.

H. Matter, H. Schreuder, M. Lorenz, 2004, Analytical biochemistry.